FDA grants quick review for 3 psychedelic drug trials

The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder.

Erika Edwards
Author: Erika Edwards

This post was originally published on NBC News.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *